Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders

Brazilian Oral Research

Volumn 25, Issue 1, 2011, Pages 34-41

  Abrahao, Aline Correa ^a   Bonelli, Beatriz Venturi ^b   Nunes, Fábio Daumas ^c   Dias, Eliane Pedra ^d   Cabral, Márcia Grillo ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Oral Pathologist of the Air Force Central Hospital   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Cyclin dependent kinase inhibitor p16; Mouth neoplasms; Telomerase; Tumor suppressor protein p53

Indexed keywords

EID: 79952172586     PISSN: 18068324     EISSN: 18073107     Source Type: Journal    
DOI: 10.1590/S1806-83242011000100007     Document Type: Article

References (24)

1. Barnes L, Eveson JW, Reichart P, Sidransky D. Editors. World Health Organization Classification of Tumours. Patholgy & Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005. 430 p.
2. Mithani SK, Mydlarz WK, Grumbine FL, Smith IM, Califano JA. Molecular genetics of premalignant oral lesions. Oral Dis. 2007 Mar;13(2):126-33.
3. Cruz I, Napier SS, van der Waal I, Snijders PJ, Walboomers JM, Lamey PJ, et al. Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland. J Clin Pathol. 2002 Feb;55(2):98-104.
4. Shah NG, Trivedi TI, Tankshali RA, Goswami JA, Shah JS, Jetly DH, et al. Molecular alterations in oral carcinogenesis: significant risk predictors in malignant transformation and tumor progression. Int J Biol Markers. 2007 Apr-Jun;22(2):132-43.
5. de Oliveira LR, Ribeiro-Silva A, Zucoloto S. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma. J Oral Pathol Med. 2007 Apr;36(4):191-7.
6. Nakahara Y, Shintani S, Mihara M, Kiyota A, Ueyama Y, Matsumura T. Alterations of Rb, p16(INK4A) and cyclin D1 in the tumorigenesis of oral squamous cell carcinomas. Cancer Lett. 2000 Nov 10;160(1):3-8.
7. Freier K, Pungs S, Flechtenmacher C, Bosch FX, Lichter P, Joos S, et al. Frequent high telomerase reverse transcriptase expression in primary oral squamous cell carcinoma. J Oral Pathol Med. 2007 May;36(5):267-72.
8. Gilley D, Tanaka H, Herbert BS. Telomere dysfunction in aging and cancer. Int J Biochem Cell Biol. 2005 May;37(5):1000-13.
9. Masutomi K, Hahn WC. Telomerase and tumorigenesis. Cancer Lett. 2003 May 15;194(2):163-72.
10. Luzar B, Poljak M, Marin IJ, Eberlinc A, Klopcic U, Gale N. Human telomerase catalytic subunit gene re-expression is an early event in oral carcinogenesis. Histopathology. 2004 Jul;45(1):13-9.
11. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007 Nov;36(10):575-80.
12. Bradley KT, Budnick SD, Logani S. Immunohistochemical detection of p16INK4a in dysplastic lesions of the oral cavity. Mod Pathol. 2006 Oct;19(10):1310-6.
13. Arduino PG, Surace A, Carbone M, Elia A, Massolini G, Gandolfo S, et al. Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up. J Oral Pathol Med. 2009 Jul;38(6):540-4.
14. Brennan M, Migliorati CA, Lockhart PB, Wray D, Al-Hashimi I, Axell T, et al. Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Mar;103 Suppl:S19.e1-12.
15. Gasco M, Crook T. The p53 network in head and neck cancer. Oral Oncol. 2003 Apr;39(3):222-31.
16. Gologan O, Barnes EL, Hunt JL. Potential diagnostic use of p16INK4A, a new marker that correlates with dysplasia in oral squamoproliferative lesions. Am J Surg Pathol. 2005 Jun;29(6):792-6.
17. Karsai S, Abel U, Roesch-Ely M, Affolter A, Hofele C, Joos S, et al. Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis. J Pathol. 2007 Feb;211(3):314-22.
18. Muirhead DM, Hoffman HT, Robinson RA. Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma. J Clin Pathol. 2006 Jul;59(7):711-5.
19. Rheinwald JG, Hahn WC, Ramsey MR, Wu JY, Guo Z, Tsao H, et al. A two-stage, p16(INK4A)-and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol Cell Biol. 2002 Jul;22(14):5157-72.
20. Angiero F, Berenzi A, Benetti A, Rossi E, Del Sordo R, Sidoni A, et al. Expression of p16, p53 and Ki-67 proteins in the progression of epithelial dysplasia of the oral cavity. Anticancer Res. 2008 Sep-Oct;28(5A):2535-9.
21. Greer Jr RO, Meyers A, Said SM, Shroyer KR. Is p16(INK4a) protein expression in oral ST lesions a reliable precancerous marker? Int J Oral Maxillofac Surg. 2008 Sep;37(9):840-6.
22. Vidal L, Gillison ML. Human papillomavirus in HNSCC: recognition of a distinct disease type. Hematol Oncol Clin North Am. 2008 Dec;22(6):1125-42, vii.
23. Tarakji B, Kujan O, Nassani MZ. An immunohistochemical study of the distribution of p 16 protein in oral mucosa in smokers, non-smokers and in frictional keratosis. Med Oral Patol Oral Cir Bucal. 2010 Sep 1;15(5):e681-4.
24. Chen HH, Yu CH, Wang JT, Liu BY, Wang YP, Sun A, et al. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan. Oral Oncol. 2007 Feb;43(2):122-9.